Regulatory process

PROOF OF CONCEPT TRIALS

proof of concept trials

ARENSIA delivers high degree of scientific and logistical expertise for Phase I/Ib/IIa and PROOF OF CONCEPT patient studies.

MORE

PHASE I SPECIAL POPULATIONS

phase i special populations

ARENSIA offers exceptional fast recruitment rates for renal and hepatic impaired patients.

MORE

REGULATORY PROCESS

regulatory process

ARENSIA has the know-how to successfully manage the regulatory process in various Eastern European countries.

MORE

REGULATORY PROCESS | CLINICAL TRIALS IN EASTERN EUROPE

Regulatory process in Romania, Republic of Moldova, Georgia and Ukraine.

ARENSIA has the know-how to successfully manage the regulatory process in Romania, Moldova, Georgia and Ukraine.

This is especially important for Phase I/II trials in patients which involve complex scientific/exploratory protocols and which – case by case – imply compensation schemes for the subjects.

In Romania the regulatory approval process takes 60 days, parallel review by Health Authority and Central Ethics Committee and it follows the EU Clinical Trials Directive. Romania joined European Union (EU) in 2007. The set of documents required for submission in Romania is similar to the other countries in the European Union. All documents, except protocol synopsis and patient related documents (which are in Romanian language), are submitted in English.

In Moldova the regulatory approval process takes 30 days, parallel review by Health Authority and Central Ethics Committee. Moldova is an EU-associated country. The submission package is similar to the one in the EU countries (CTA Form not required, sample CRF required). The main documents (such as IB, Protocol, etc.) are submitted in English. The ICF language is Romanian (which is official language in Moldova) and Russian.  

In Georgia the regulatory approval process takes 30 working days. Georgia is an EU-associated country. The submission package is similar to the one in the EU countries (CTA Form not required, IMPD not required, sample CRF translated in Georgian language required). The review by the local EC takes 14 days, followed by review from Health Authority (Drug Agency), which takes further 20 working days. Study protocol and patient related documents are submitted in Georgian language. IB is submitted in English.

In Ukraine the regulatory approval process takes 60 calendar days. The submission of the study documents is done in parallel to both the regulatory authority, State Expert Center (SEC) and to the Local Ethics Committee body (LEC). Ukraine is an EU-associated country (CTA Form equivalent and IMPD required for submission). The expert evaluation of an application dossier submitted to the SEC, in validated format, takes 47 calendar days. The conclusion given by SEC is approved by the Ministry of Health (up to10 calendar days). The assessment of an application dossier submitted to LEC, in validated format, takes 30 calendar days. Study protocol synopsis and patient related documents are submitted in Ukrainian language. IB is submitted in English.

The regulatory bodies in these countries request solid scientific data and thoroughly developed protocols for clinical trials in Eastern Europe.

We are glad to offer detailed information as guidance through the process and the set of documents required for submission of study dossier in each of these countries. Please contact us at info@arensia-em.com.

Useful links: